Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/94113
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPhillips, L.K.-
dc.contributor.authorDeane, A.M.-
dc.contributor.authorJones, K.L.-
dc.contributor.authorRayner, C.K.-
dc.contributor.authorHorowitz, M.-
dc.date.issued2015-
dc.identifier.citationNature Reviews Endocrinology, 2015; 11(2):112-128-
dc.identifier.issn1759-5029-
dc.identifier.issn1759-5037-
dc.identifier.urihttp://hdl.handle.net/2440/94113-
dc.description.abstractThe rate of gastric emptying is a critical determinant of postprandial glycaemia and, accordingly, is fundamental to maintaining blood glucose homeostasis. Disordered gastric emptying occurs frequently in patients with longstanding type 1 diabetes mellitus and type 2 diabetes mellitus (T2DM). A complex bidirectional relationship exists between gastric emptying and glycaemia--gastric emptying accounts for ∼35% of the variance in peak postprandial blood glucose concentrations in healthy individuals and in patients with diabetes mellitus, and the rate of emptying is itself modulated by acute changes in glycaemia. Clinical implementation of incretin-based therapies for the management of T2DM, which diminish postprandial glycaemia, in part by slowing gastric emptying, is widespread. Other therapies for patients with T2DM, which specifically target gastric emptying include pramlintide and dietary-based treatment approaches. A weak association exists between upper gastrointestinal symptoms and the rate of gastric emptying. In patients with severe diabetic gastroparesis, pathological changes are highly variable and are characterized by loss of interstitial cells of Cajal and an immune infiltrate. Management options for patients with symptomatic gastroparesis remain limited in their efficacy, which probably reflects the heterogeneous nature of the underlying pathophysiology.-
dc.description.statementofresponsibilityLiza K. Phillips, Adam M. Deane, Karen L. Jones, Chris K. Rayner, Michael Horowitz-
dc.language.isoen-
dc.publisherNature Publishing Group-
dc.rights© 2015 Macmillan Publishers Limited. All rights reserved-
dc.source.urihttp://dx.doi.org/10.1038/nrendo.2014.202-
dc.subjectHumans-
dc.subjectHyperglycemia-
dc.subjectHypoglycemic Agents-
dc.subjectGastric Emptying-
dc.subjectPostprandial Period-
dc.titleGastric emptying and glycaemia in health and diabetes mellitus-
dc.typeJournal article-
dc.identifier.doi10.1038/nrendo.2014.202-
pubs.publication-statusPublished-
dc.identifier.orcidPhillips, L.K. [0000-0002-9066-717X]-
dc.identifier.orcidDeane, A.M. [0000-0002-7620-5577]-
dc.identifier.orcidJones, K.L. [0000-0002-1155-5816]-
dc.identifier.orcidRayner, C.K. [0000-0002-5527-256X]-
dc.identifier.orcidHorowitz, M. [0000-0002-0942-0306]-
Appears in Collections:Aurora harvest 2
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.